BASF adds active drug substance to portfolio

BASF has added phenylephrine hydrochloride to its portfolio. The well-established substance is used in nasal sprays to helps nasal membranes to decongest.

BASF has added phenylephrine hydrochloride to its portfolio. The well-established substance is used in nasal sprays to helps nasal membranes to decongest.

This addition strengthens BASF's position on the global market for cold remedies. Phenylephrine hydrochloride is produced at the company's site in Minden, Germany, as it is ideally suited to the plants and technologies already in place. The pharmaceutical site also meets all cGMP (current Good Manufacturing Practice) guidelines and FDA requirements.

"The offering is BASF's response to increased demand for this tried and tested pharmaceutical ingredient. Phenylephrine is particularly popular in the US, the world's largest market for cold remedies," said Brigitte Sebastian, head of global marketing for active pharmaceutical ingredients at BASF.

Featured Companies

BASF Care Creations (more information, website)